CEO of ViralClear, Nick Spring, and COO of ViralClear, Steve King joined AM Tampa Bay to discuss Catalent just announced that it is partnering with ViralClearPharmaceuticals to work on the development of a potential treatment for adults with COVID-19. (Catalent will work on the program at its St. Petersburg, Florida, facility)
To learn more on this topic click here